首页|期刊导航|国际肝胆胰疾病杂志:英文版|Obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver disease
国际肝胆胰疾病杂志:英文版2022,Vol.21Issue(3):P.241-247,7.DOI:10.1016/j.hbpd.2022.03.009
Obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver disease
摘要
关键词
Metabolic dysfunction-associated fatty liver disease/Metabolically-healthy obesity/Liver fibrosis分类
医药卫生引用本文复制引用
Ji Hye Huh,Kwang Joon Kim,Seung Up Kim,Bong-Soo Cha,Byung-Wan Lee..Obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver disease[J].国际肝胆胰疾病杂志:英文版,2022,21(3):P.241-247,7.基金项目
supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea(NRF)funded by the Ministry of Education,Science and Technology(2020R1F1A1076198)。 (NRF)